SEQUENTIAL STUDY ON THE INCIDENCE AND INTENSITY OF INTESTINAL CONSTIPATION ASSOCIATED TO OXYCODONE (OXYCONTIN) AND THE COMBINATION OF OXYCODONE/NALOXONE (TARGIN) FOR CHRONIC ONCOLOGIC PAIN TREATMENT (ONCO_PAIN 01/2009).

Trial Profile

SEQUENTIAL STUDY ON THE INCIDENCE AND INTENSITY OF INTESTINAL CONSTIPATION ASSOCIATED TO OXYCODONE (OXYCONTIN) AND THE COMBINATION OF OXYCODONE/NALOXONE (TARGIN) FOR CHRONIC ONCOLOGIC PAIN TREATMENT (ONCO_PAIN 01/2009).

Recruiting
Phase of Trial: Phase III

Latest Information Update: 21 Apr 2012

At a glance

  • Drugs Oxycodone/naloxone (Primary) ; Oxycodone
  • Indications Cancer pain; Constipation
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Apr 2012 Planned end date 23 Nov 2010 added as reported by European Clinical Trials Database record.
    • 21 Apr 2012 Actual initiation date (23 April 2010) added as reported by European Clinical Trials Database record.
    • 22 Mar 2012 Planned number of patients changed to 30.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top